Aura Biosciences, Inc.
85 Bolton Street
At Aura Biosciences, we are developing a new class of therapies to target and destroy cancer cells selectively, while leaving surrounding tissue unharmed – an approach we call molecular surgery. By safely eliminating cancer locally, we can treat early and transform the lives of people with a wide range of cancers that are poorly managed today.
Founder and CEO: Elisabet de los Pinos
COO: Alison Lawton
CFO: Michael Wyzga
Please click here for Aura job opportunities.
Please click here for clinical trial information.